RE
Healthcare & Life Sciences

ReveraGen

ReveraGen is a Healthcare & Life Sciences startup.

View Full Profile

About ReveraGen

ReveraGen is a startup. Brouky classifies it under Healthcare & Life Sciences.

ReveraGen is developing an anti-inflammatory treatment for Duchenne muscular dystrophy with fewer side effects than current glucocorticoids.

Explore ReveraGen's full profile on Brouky

Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.

View Startup Profile →View pricing